In the current economic context, the healthcare industry is facing constant pressure to control health expenditure. But we are not only facing a situation where we have to simply weather the storm. This is a structural crisis that requires structural changes. One of the major victories of the 20th century has been the lengthening of our lives and here healthcare systems and the health industry have been at the center of the achievement. However, longer lives imply different needs of healthcare, promotion and prevention.

Our healthcare systems have to change in response to the miracle they have produced. Now, more than ever, we have to ensure that we define a sustainable long-term strategy that leads us to use the available resources in the best possible way to guarantee their contribution to value creation. Elements such as technology, new ways of helping patients take a more active role, public-private partnerships, agreements and alliances, are key.

We need to seek new business models that facilitate coordination among all agents involved and foster value sharing to leverage the contributions that new organizational models and new technological and pharmaceutical products can bring to patients’ health. It is imperative that all the agents involved in healthcare, including politicians, patients, doctors, hospitals, nurses, pharmacist, pharmaceutical and medical device companies, come together to start thinking about what works and why.

The IESE Healthcare Meeting offers a first-class platform for the exchange of perspectives among top executives, academics and healthcare professionals. It will combine keynote speakers, who will share their insight into the current state and the future of the sector, with several panels that will allow participants to share experiences and impressions about the key topics in today’s healthcare industry.

This meeting is aimed at entrepreneurs, presidents, managing directors, CEOs and senior executives in the pharmaceutical industry, the health-technology industry, hospitals and anyone working in the healthcare industry. It will also appeal to people responsible for government healthcare policies and public healthcare institutions.

The following topics will be covered by speakers in the fields of academia, health technology, pharmaceuticals, biotech, government, insurance, hospital management and other players in the healthcare industry.

Global Economics
• Impact of the Current Economic Environment and Future Trends in the Healthcare Industry.
• How do Markets See the Healthcare Industry? Key Indicators and the Perspective of Investors.

Healthcare Systems
• Health, Quality and Regulation. How Can Regulation Help Our Healthcare Systems and Their Agents Focus on Value Creation?
• Strategic Priorities
• How Can Healthcare Systems Create More Value? International Experiences
• Digitization: Is Technology About to Revolutionize Healthcare? The Role of Genomics, Mobile Devices, Social Networks, etc.

The View of Professionals
• Keys for Excellence in Healthcare

The Point of View of the Public Sector
• Developing Public-Private Partnerships

The Insurer’s Perspective
• Opportunities and Strategies for Private Insurers Facing the Reorganization of Healthcare in Europe

The Vision of the Life Sciences Industry
• Priorities for Pharmaceutical, Medical Devices and Biotech Companies
in the Face of Budget Constraints
• Value Creation in the Industry
• The Healthcare Industry Has Been a “Value Creator” Par Excellence. How Can Healthcare Systems Exploit This Value? What Mechanisms Could Be Activated From the Industry? Can “Value Sharing” Help?
• Growth and Competitiveness
• Challenges and Opportunities for the Companies of This Industry in High-Potential Markets. The BRICS
• New Players From Emerging Markets

Innovation
• Innovating in the Healthcare Ecosystem
• International Models and Experiences